attachment
attachment

Solve the paper according to marks

Reading File
Finding Sources
Finding Sources
Finding Sources

GMERS Medical College - Community Medicine Theory Paper-II

Complete Model Answers


SECTION I


Q-1(a): Essential Obstetric Care, RMNCH+A Services & Maternal Death Review (2+5+3 = 10 marks)

What is Essential Obstetric Care? (2 marks)

Essential Obstetric Care (EOC) refers to the set of standard obstetric services that must be available at all levels of the health system to ensure safe motherhood. It is divided into:
  • Basic Essential Obstetric Care (BEOC) - provided at PHC/CHC level:
    • Parenteral antibiotics
    • Parenteral oxytocics
    • Parenteral anticonvulsants (MgSO4)
    • Manual removal of placenta
    • Removal of retained products
    • Assisted vaginal delivery (vacuum/forceps)
    • Neonatal resuscitation
  • Comprehensive Essential Obstetric Care (CEOC) - provided at FRU/District Hospital level:
    • All BEOC services +
    • Caesarean section
    • Blood transfusion
    • Management of complications

Services under RMNCH+A Programme (5 marks)

RMNCH+A = Reproductive, Maternal, Newborn, Child Health + Adolescent Health. Launched in 2013, it is a strategic approach that integrates services across the life cycle.
Services delivered:
1. Reproductive Health:
  • Family planning services (spacing and limiting methods)
  • Prevention and management of RTIs/STIs
  • Post-abortion care
  • Infertility services
2. Maternal Health:
  • ANC (at least 4 visits; now 8 as per WHO)
  • Institutional delivery promotion - JSY, JSSK
  • Emergency obstetric care
  • Skilled birth attendance
  • Postnatal care (at least 3 visits - within 48 hrs, 3-7 days, 6 weeks)
  • Prevention and treatment of anaemia (IFA supplementation)
  • PMSMA (Pradhan Mantri Surakshit Matritva Abhiyan) - free ANC on 9th of every month
3. Newborn Health:
  • Facility-based newborn care (SNCU, NBSU, NBCC)
  • IMNCI
  • Home-based newborn care (HBNC)
  • Kangaroo Mother Care
  • Promotion of exclusive breastfeeding
4. Child Health:
  • Immunization (UIP - Universal Immunization Programme)
  • IMNCI / IMCI
  • Management of malnutrition (NRCs)
  • Vitamin A supplementation
  • Oral Rehydration Therapy
5. Adolescent Health (+A):
  • RKSK (Rashtriya Kishor Swasthya Karyakram)
  • WIFS (Weekly Iron & Folic Acid Supplementation)
  • Adolescent-friendly health clinics (AFHCs)
  • Menstrual hygiene, nutrition, ARSH services

Importance of Maternal Death Review (MDR) (3 marks)

MDR is a qualitative, in-depth investigation of the causes and circumstances surrounding each maternal death, conducted at facility or community level.
Importance:
  1. Identifies avoidable factors - the "three delays" (delay in deciding to seek care, reaching facility, receiving adequate care)
  2. Guides corrective action - helps health system plug gaps in service delivery
  3. Improves accountability - VHSNC and health facility staff are involved in reviewing deaths
  4. Evidence for planning - local data informs district and state health planning
  5. Reduces future deaths - by learning from each death, similar deaths can be prevented
  6. Mandatory under government policy - all maternal deaths in government facilities and community must be reported and reviewed (Form 4A/5A)

Q-1(b): MMR - Definition, India & Gujarat MMR, Causes, Interventions (1+2+3+4 = 10 marks)

Definition of MMR (1 mark)

Maternal Mortality Rate (MMR) is the number of maternal deaths due to complications of pregnancy, childbirth, or within 42 days of termination of pregnancy (from any cause related to or aggravated by pregnancy) per 1,00,000 live births in a given year.
$$MMR = \frac{\text{Number of maternal deaths}}{\text{Number of live births}} \times 1,00,000$$

Latest MMR of Gujarat and India (2 marks)

MMR (per 1,00,000 live births)
India (SRS 2018-20)97
Gujarat (SRS 2018-20)57
  • India's MMR has declined from 254 (2004-06) to 97 (2018-20) - a significant reduction
  • SDG target: MMR < 70 by 2030
  • Gujarat performs better than national average

Various Causes of Maternal Deaths (3 marks)

Direct Obstetric Causes (~75%):
  1. Haemorrhage (PPH, APH) - most common cause (~27%)
  2. Sepsis / Puerperal sepsis
  3. Hypertensive disorders (eclampsia, pre-eclampsia)
  4. Obstructed labour
  5. Unsafe abortion complications
  6. Embolism (amniotic fluid, pulmonary)
Indirect Causes (~25%):
  • Anaemia (most important indirect cause in India)
  • Malaria
  • Hepatitis
  • Heart disease
  • Tuberculosis
  • Diabetes
Three Delays Model:
  • Delay 1: Deciding to seek care (social, financial, awareness issues)
  • Delay 2: Reaching the facility (transport, distance)
  • Delay 3: Receiving adequate care (human resource, equipment deficit)

Recent Interventions for Improving Maternal Mortality (4 marks)

  1. JSY (Janani Suraksha Yojana) - conditional cash transfer to promote institutional delivery; targets BPL women in low-performing states (LPS); provides Rs. 1400 (rural) and Rs. 1000 (urban) in high focus states
  2. JSSK (Janani Shishu Suraksha Karyakram) - free services for pregnant women and sick newborns including free delivery, C-section, drugs, diagnostics, blood, diet, transport (both ways), and no user charges
  3. PMSMA (Pradhan Mantri Surakshit Matritva Abhiyan) - free ANC by specialists/MOs on 9th of every month at government health facilities
  4. LaQshya Programme - improving quality of care in Labour Rooms and Maternity Operation Theatres
  5. Surakshit Matritva Aashwasan (SUMAN) - assured, dignified, respectful maternity care with zero tolerance for denial of services
  6. Anaemia Mukt Bharat - addressing anaemia as major indirect cause through IFA, deworming, dietary diversification
  7. Skilled Birth Attendance - training of ANMs and nurses as Skilled Birth Attendants (SBAs)
  8. MDR (Maternal Death Review) - systematic review and learning from every maternal death

SECTION II


Q-2(a): 50-day infant, Cough, RR>60/min, Chest Indrawing (1+2+3 = 6 marks)

1. Provisional Diagnosis (1 mark)

Severe Pneumonia (as per IMCI/IMNCI classification)
Basis: Age < 2 months, cough + fast breathing (RR > 60/min in infants < 2 months) + chest indrawing - the presence of chest indrawing in a young infant (< 2 months) automatically classifies as severe disease.

2. Common Organisms Involved (2 marks)

In young infants (0-2 months), the pathogens differ from older children:
Bacterial (most common):
  • Group B Streptococcus (GBS) - most common in neonates
  • Klebsiella pneumoniae
  • E. coli and other Gram-negative bacilli
  • Staphylococcus aureus - especially in community-acquired cases
  • Streptococcus pneumoniae (Pneumococcus) - less in this age group
  • Chlamydia trachomatis - afebrile pneumonitis (staccato cough)
Viral:
  • RSV (Respiratory Syncytial Virus)
  • Cytomegalovirus

3. Classification and Management of Pneumonia in Young Infants (3 marks)

IMNCI Classification (Age < 2 months):
ClassificationSignsAction
Severe DiseaseChest indrawing OR fast breathing (>60/min) OR any danger signUrgent referral to hospital; give first dose of IM antibiotics
Severe Disease (danger signs)Stopped feeding well, convulsions, abnormally sleepy, stridor, wheeze, fever/low body temp, nasal flareAdmit immediately
Management:
Hospital Management (Severe Pneumonia in Young Infant):
  1. Admit to SNCU/NBSU
  2. Antibiotics: Injection Ampicillin + Injection Gentamicin (first-line for young infants)
    • Alternative: Injection Cefotaxime
  3. Oxygen therapy if SpO2 < 90% or severe respiratory distress
  4. Supportive care:
    • Maintain temperature (avoid hypothermia)
    • IV fluids if not feeding
    • Nasogastric feeds if feeding poorly
    • Monitor RR, temperature, feeding every 3-4 hours
  5. Duration: 7-10 days antibiotics
  6. After improvement, switch to oral antibiotics and continue for total 10 days
  7. Follow-up in 2 days after discharge

Q-2(b): 30-yr woman, Multiple Hypo-pigmented Patches - Diagnosis & Management (2+4 = 6 marks)

Diagnosis (2 marks)

Leprosy (Hansen's Disease)
The presence of more than 5 hypo-pigmented patches on different parts of the body in a 30-year-old woman is consistent with Multibacillary (MB) Leprosy (Lepromatous/Borderline lepromatous type).
Basis for diagnosis:
  • Multiple (>5) hypo-pigmented patches
  • Distribution over different body parts
  • Cardinal signs of leprosy: hypopigmented macules/patches, loss of sensation, thickened nerves
  • Skin smear (slit skin smear) may show AFB (acid-fast bacilli)
Classification:
  • Paucibacillary (PB): 1-5 patches, smear negative
  • Multibacillary (MB): >5 patches, smear positive

Management as per National Programme - NLEP (4 marks)

Under the National Leprosy Eradication Programme (NLEP), treatment is by Multi-Drug Therapy (MDT) provided free of charge:
MDT for Multibacillary (MB) Leprosy - 12 months:
DrugMonthly Supervised DoseDaily Self-administered Dose
Rifampicin600 mg (supervised)-
Dapsone100 mg (supervised)100 mg daily
Clofazimine300 mg (supervised)50 mg daily
  • Duration: 12 months for MB leprosy
  • Drugs dispensed: Monthly blister packs (MDT blister pack)
Additional management steps:
  1. Disability assessment at diagnosis and during treatment
  2. Nerve function assessment - test for sensory and motor involvement
  3. Reaction management:
    • Type 1 (Reversal Reaction): Prednisolone
    • Type 2 (ENL - Erythema Nodosum Leprosum): Thalidomide/Clofazimine/Prednisolone
  4. Prevention of disabilities (POD):
    • Self-care (soaking, oiling, scraping)
    • Protective footwear
    • Eye care, physiotherapy
  5. Contact examination - screen household contacts
  6. Health education - reduce stigma, ensure treatment compliance
  7. Post-exposure prophylaxis: Single dose Rifampicin (SDR) for contacts

Q-2(c): Contraceptive Methods - Classification & Injectable Contraceptives (2+4 = 6 marks)

Two Broad Classifications with List of Contraceptive Methods (2 marks)

Classification 1: Based on Duration/Reversibility
TypeMethods
Temporary (Spacing) MethodsBarrier, Hormonal (OCP, injectable, implants), IUCDs, Natural methods
Permanent (Terminal) MethodsTubectomy (female), Vasectomy (male)
Classification 2: Based on Mechanism
A. Barrier Methods:
  • Male condom
  • Female condom
  • Diaphragm
  • Cervical cap
  • Spermicides
B. Hormonal Methods:
  • Combined Oral Contraceptive Pills (COCPs) - e.g., Mala-N, Mala-D
  • Progestin-only Pills (Mini pill) - e.g., Chhaya
  • Injectable contraceptives - DMPA (Antara)
  • Implants (Implanon)
  • Emergency contraceptive pills (ECPs) - i-Pill, Unwanted 72
C. Intrauterine Devices (IUCDs):
  • Non-medicated (Lippes Loop - historical)
  • Copper IUCDs - CuT 380A (10 years), CuT 200B (3 years)
  • Hormonal IUD - Levonorgestrel IUS (Mirena)
D. Natural Methods:
  • Rhythm/Calendar method
  • Basal Body Temperature (BBT) method
  • Cervical mucus method (Billings method)
  • Lactational Amenorrhea Method (LAM)
  • Coitus interruptus (withdrawal)
E. Terminal Methods:
  • Female sterilization: Tubectomy (Minilap, Laparoscopic)
  • Male sterilization: Vasectomy (Conventional, No-scalpel vasectomy - NSV)

Injectable Contraceptive Methods (4 marks)

1. DMPA - Depot Medroxyprogesterone Acetate (Antara Programme in India)
  • Brand: Depo-Provera; Government programme: Antara
  • Dose: 150 mg IM injection
  • Frequency: Every 3 months (13 weeks)
  • Mechanism: Inhibits ovulation, thickens cervical mucus, atrophies endometrium
  • First dose: Within 7 days of menstrual cycle start (or immediately postpartum if not breastfeeding)
  • Efficacy: >99% (0.3 pregnancies per 100 woman-years)
  • Advantages:
    • Long-acting (3 monthly)
    • No daily compliance needed
    • Does not interfere with intercourse
    • Can be used by breastfeeding mothers (after 6 weeks postpartum)
    • Reduces menorrhagia and dysmenorrhea
  • Disadvantages/Side effects:
    • Menstrual irregularities (amenorrhoea, irregular bleeding)
    • Delayed return of fertility (up to 12-18 months after stopping)
    • Weight gain, mood changes
    • Decreased bone mineral density (long-term use)
    • No protection against STIs
2. NET-EN - Norethisterone Enanthate
  • Dose: 200 mg IM every 2 months
  • Less commonly used in India
3. Combined Injectable Contraceptives (CIC):
  • Monthly injectable - estrogen + progestogen
  • e.g., Cyclofem (DMPA 25mg + estradiol cypionate 5mg) - monthly
Under Antara Programme (India):
  • Launched 2016-17 to provide injectable contraceptives at public health facilities
  • ASHA facilitates clients to health facility
  • Given free of cost
  • Offered to eligible couples wanting spacing

SECTION III


Q-3(a): Social Factors in STDs & Preventive/Control Measures (3+3 = 6 marks)

Social Factors Involved in Spread of STDs (3 marks)

  1. Poverty and economic deprivation - drives commercial sex work; lack of access to healthcare
  2. Urbanization and migration - male migration to cities leads to high-risk sexual behaviour; truck drivers, migrant workers are high-risk groups
  3. Commercial sex work (CSW) - sex workers and their clients form a core group for STI transmission; multiple sexual partners
  4. Substance abuse - alcohol and drug use reduces inhibitions, leads to unsafe sex; IV drug users share needles (HIV/Hepatitis B)
  5. Low literacy and lack of awareness - ignorance about modes of transmission, symptoms, and condom use
  6. Stigma and discrimination - fear of social ostracism prevents seeking timely treatment; self-medication common
  7. Gender inequality - women unable to negotiate safe sex; violence against women
  8. Cultural and social norms - taboo surrounding sex education; lack of open discussion
  9. High-risk populations - MSM (Men who have Sex with Men), transgenders, prisoners - socially marginalized, less access to services
  10. Marriage practices - early marriage, polygamy

Preventive and Control Measures (3 marks)

A. Primary Prevention:
  1. Health education - sex education in schools, IEC campaigns, mass media
  2. Condom promotion and distribution - 100% condom use programme (CUP) at high-risk sites
  3. Safe sexual behaviour - ABC (Abstinence, Be faithful, Condom use)
  4. Needle exchange programmes - for IV drug users
  5. Targeted Interventions (TI) under NACP - for FSW, MSM, truckers, migrants
  6. Vaccination - Hepatitis B vaccine, HPV vaccine (for cervical cancer/HPV)
B. Secondary Prevention (Early Detection & Treatment):
  1. Syndromic case management - treat based on syndrome (urethral discharge, vaginal discharge, genital ulcer) without waiting for lab results
  2. Icteric STI clinics - free diagnosis and treatment
  3. Partner notification and treatment - contact tracing, treatment of sexual partners
  4. ICTC (Integrated Counselling and Testing Centres) - for HIV testing
C. Tertiary Prevention:
  1. ART (Antiretroviral Therapy) for HIV under NACP
  2. Treatment of complications - PID, infertility, neonatal ophthalmia
D. Specific Programmes:
  • NACP (National AIDS Control Programme) - Phase IV
  • National STI/RTI control programme
  • PPTCT - Prevention of Parent to Child Transmission of HIV

Q-3(b): Geriatric Health Problems and Preventive Measures (3+3 = 6 marks)

Geriatric Health Problems (3 marks)

Geriatrics deals with persons aged 60 years and above. The "4 Ds of old age" and key health problems:
1. Physical Problems:
  • Cardiovascular diseases - hypertension, coronary artery disease, heart failure
  • Musculoskeletal - osteoarthritis, osteoporosis, fractures (esp. hip and spine), sarcopenia
  • Neurological - dementia (Alzheimer's), Parkinson's disease, stroke, peripheral neuropathy
  • Sensory deficits - presbyopia, cataract, glaucoma; presbycusis (hearing loss)
  • Urinary problems - benign prostatic hypertrophy, urinary incontinence
  • Diabetes mellitus - common in elderly
  • Falls and injuries - leading cause of morbidity; due to poor balance, polypharmacy
  • Malignancies - increased cancer incidence with age
  • Dental problems - tooth loss, poor nutrition
2. Mental Health Problems ("5 Ds"):
  • Dementia - progressive memory loss (Alzheimer's most common)
  • Depression - very common, often under-diagnosed
  • Delirium - acute confusional state
  • Drug problems - polypharmacy, adverse drug reactions
3. Social Problems:
  • Social isolation, loneliness
  • Financial dependence
  • Elder abuse (physical, emotional, financial)
  • Retirement and loss of identity/purpose
4. Nutritional Problems:
  • Malnutrition, vitamin D and calcium deficiency
  • Dysphagia

Preventive Measures (3 marks)

1. Primary Prevention:
  • Regular physical exercise (walking, yoga) - prevents CVD, osteoporosis, depression
  • Balanced diet - adequate protein, calcium, vitamin D
  • Weight management
  • Avoid smoking, limit alcohol
  • Immunization - annual influenza vaccine, pneumococcal vaccine, Td booster
  • Fall prevention - home safety modifications (remove loose carpets, grab bars), appropriate footwear
  • Regular blood pressure and blood sugar monitoring
  • Mental stimulation activities to delay dementia
2. Secondary Prevention (Screening):
  • Geriatric assessment clinics - Comprehensive Geriatric Assessment (CGA)
  • Screening for hypertension, diabetes, cancers (breast, cervical, colorectal, prostate)
  • Vision and hearing screening and correction
  • Bone mineral density (DEXA scan) for osteoporosis
  • Depression screening (GDS - Geriatric Depression Scale)
  • Cognitive screening (MMSE)
3. Tertiary Prevention:
  • Rehabilitation services - physiotherapy, occupational therapy
  • Palliative care
  • Home-based care services
  • Day care centres for elderly
4. Government Initiatives:
  • NPHCE (National Programme for Health Care of the Elderly) - launched 2010
    • Dedicated geriatric wards at district hospitals
    • Geriatric OPD at CHC/DH
    • Training of health workers
  • Maintenance and Welfare of Parents and Senior Citizens Act, 2007
  • Old Age Homes, Pension schemes

Q-3(c): Drug Dependence vs Drug Addiction (6 marks)

These are NOT synonymous though related concepts.

Drug Dependence

Definition (WHO): A state, psychic and sometimes physical, resulting from the interaction between a living organism and a drug, characterized by behavioural and other responses that always include a compulsion to take the drug on a continuous or periodic basis in order to experience its psychic effects, and sometimes to avoid the discomfort of its absence.
Types:
  1. Physical (Physiological) Dependence: The body adapts to the presence of the drug; abrupt withdrawal produces physical withdrawal symptoms (e.g., tremors, sweating, seizures with alcohol withdrawal)
  2. Psychological (Psychic) Dependence: Emotional/mental need to take the drug for pleasure or to relieve discomfort; no significant physical withdrawal signs
Features:
  • May exist without addiction (e.g., a patient on long-term opioids for cancer pain is physically dependent but not addicted)
  • Focus is on the biological adaptation of the body

Drug Addiction

Definition: A chronic, relapsing brain disorder characterized by compulsive drug seeking and use despite harmful consequences. It involves loss of control over drug use.
Features:
  1. Compulsive craving for the drug
  2. Loss of control - cannot stop despite wanting to
  3. Continued use despite adverse consequences (social, occupational, medical)
  4. Tolerance - need increasing amounts to achieve the same effect
  5. Preoccupation with obtaining the drug
  6. Relapse after periods of abstinence

Key Differences

FeatureDrug DependenceDrug Addiction
NaturePhysiological/psychological adaptationBehavioural/compulsive pattern
WithdrawalPhysical symptoms on stopping (physical dependence)May or may not have physical withdrawal
ControlMay still have controlLoss of control is central
ConsequenceNot necessarily harmful in medical useHarmful consequences persist despite use
ExamplePatient on long-term corticosteroids or opioid analgesiaHeroin addict seeking drug compulsively
ScopeBroader term (includes physical + psychological)More specific - behaviour + compulsion + harm
Modern terminologyWHO prefers "dependence syndrome"DSM-5 uses "Substance Use Disorder"
In summary: All addiction involves dependence, but not all dependence is addiction. Dependence is a physiological state; addiction is a complex biopsychosocial disorder involving compulsive drug-seeking behaviour.

Q-3(d): Fertility Indicators, NRR=1, Terminal Contraceptive Methods (2+1+3 = 6 marks)

Fertility Indicators (2 marks)

  1. Crude Birth Rate (CBR): Number of live births per 1000 mid-year population per year
    • India CBR: ~20 (SRS 2020)
  2. General Fertility Rate (GFR): Number of live births per 1000 women aged 15-44 (or 15-49) years per year
  3. Age-Specific Fertility Rate (ASFR): Live births per 1000 women of a specific age group per year
  4. Total Fertility Rate (TFR): Average number of children a woman would have if she experienced current age-specific fertility rates throughout her reproductive lifespan (15-49 years)
    • India TFR: 2.0 (NFHS-5, 2019-21) - at replacement level
    • Replacement level TFR = 2.1
  5. Gross Reproduction Rate (GRR): Average number of girl children born to a woman during her reproductive period (15-49 years)
  6. Net Reproduction Rate (NRR): Average number of girl children a woman will have who survive to reproductive age, taking into account mortality rates

NRR = 1 (1 mark)

NRR = 1 means that each generation is exactly replacing itself. One woman is replaced by exactly one daughter who survives to reproductive age. It represents population equilibrium - neither growth nor decline. In practical terms, when NRR = 1, the population will eventually become stationary (zero population growth) once the age structure stabilizes.

Terminal Contraceptive Methods - Advantages and Disadvantages (3 marks)

Terminal Methods = Permanent Sterilization = Tubectomy (female) + Vasectomy (male)
Advantages:
  1. Highly effective - close to 100% (failure rate: tubectomy ~0.5%, vasectomy ~0.1 per 100 woman-years)
  2. One-time procedure - no need for daily/monthly compliance
  3. Cost-effective in long run
  4. No hormonal side effects - natural menstrual cycles and hormone levels unchanged
  5. No interference with sexual intercourse, libido, or sexual pleasure
  6. Immediate effect (tubectomy) - effective from the day of procedure
Disadvantages:
  1. Permanent/Irreversible - reversal (recanalization) is technically difficult, expensive, and not always successful
  2. Requires surgical procedure - carries surgical and anaesthetic risks (bleeding, infection, anaesthetic complications)
  3. No protection against STIs/HIV
  4. Regret - especially if done at young age, child death, or remarriage
  5. Failure - can rarely fail (ectopic pregnancy risk in tubectomy failure)
  6. Vasectomy: Small delay in effectiveness - requires semen analysis after 12 weeks to confirm azoospermia
  7. Social/cultural resistance - especially for male sterilization in India
Government incentive: Cash compensation under RCH programme for sterilization acceptors.

SECTION IV (Q-4)

Any 5 out of 6 (2 marks each)


(a) MTP Act and New Amendments

The Medical Termination of Pregnancy (MTP) Act, 1971 legalizes abortion in India under specified conditions. Under the original Act, pregnancy up to 12 weeks could be terminated by a registered medical practitioner (RMP), and between 12-20 weeks by two RMPs, on grounds including contraceptive failure, rape, foetal abnormalities, risk to mother's health.
MTP Amendment Act 2021:
  • Upper gestational limit extended from 20 to 24 weeks for specific categories (rape survivors, incest victims, differently-abled women, minors, change in marital status)
  • For pregnancies beyond 24 weeks with foetal abnormalities, decision by State-level Medical Board
  • Opinion of one RMP (instead of two) now required for terminations up to 20 weeks (was 12 weeks)
  • Provider's identity and that of the woman kept confidential

(b) At-risk Infants

At-risk infants are those with an increased probability of illness, developmental problems, or death compared to the general infant population. They include: low birth weight infants (<2500g), premature (<37 weeks), infants born to mothers with infections (HIV, hepatitis, TB, syphilis), infants with birth asphyxia, congenital anomalies, neonatal jaundice, twins/multiple births, and infants of diabetic mothers. These infants require special follow-up, monitoring, and care (registered in "at-risk register" at health facilities).

(c) Difference Between Eugenics and Euthenics

Eugenics is the science of improving the genetic composition of a population by encouraging reproduction of individuals with desirable traits and discouraging (or preventing) reproduction of those with undesirable genetic traits - it operates by changing the genetic makeup (nature). Example: Selective breeding, genetic counselling.
Euthenics is the science of improving human beings by improving their environment - it operates by changing living conditions (nutrition, sanitation, education, housing) to allow full development of human potential - it changes nurture, not genes. Example: Better nutrition, clean water supply, improved housing.
Key: Eugenics = genetic improvement; Euthenics = environmental improvement.

(d) Two Warning Signs of Poor Mental Health

  1. Persistent low mood or sadness lasting more than two weeks, loss of interest in previously enjoyed activities, feelings of hopelessness or worthlessness - suggestive of depression
  2. Social withdrawal and isolation - withdrawing from friends, family, and usual social activities; neglecting personal hygiene and responsibilities, which can indicate depression, anxiety, or early psychosis

(e) Unmet Need for Family Planning

Unmet need for family planning refers to the proportion of married women of reproductive age (15-49 years) who want to stop or delay childbearing but are not using any contraceptive method. It is an important indicator of family planning programme performance. In India (NFHS-5), unmet need is approximately 9.4%. It includes two components: unmet need for spacing (want to delay next birth) and unmet need for limiting (want no more children). High unmet need suggests gaps in service availability, access, awareness, or acceptability.

(f) Informed Consent

Informed consent is the process by which a patient voluntarily agrees to a medical procedure or treatment after being adequately informed of the nature of the procedure, its risks and benefits, available alternatives, and consequences of refusing. It must be voluntary (free from coercion), informed (complete and understandable information), and the person must have decision-making capacity. It is ethically and legally mandatory before any surgical procedure, research participation, HIV testing, or invasive diagnostic test. For minors (<18 years) or incompetent adults, consent is taken from the legal guardian.

Reference: Park's Textbook of Preventive & Social Medicine (25th Edition, K. Park); IMNCI/IMCI Guidelines; National Health Mission Documents; NLEP Guidelines; NACP Phase IV; SRS 2018-20; NFHS-5 (2019-21).
This is a shared conversation. Sign in to Orris to start your own chat.